4//SEC Filing
Pankovcin Corinne 4
Accession 0001213900-20-035131
CIK 0001726711other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 9:31 PM ET
Size
7.6 KB
Accession
0001213900-20-035131
Insider Transaction Report
Form 4
Pankovcin Corinne
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2020-11-02+15,000→ 15,000 totalExercise: $1.92From: 2020-11-02Exp: 2030-11-02→ Common Stock (15,000 underlying) - Award
Stock Option (Right to Buy)
2020-11-02+165,000→ 165,000 totalExercise: $1.92Exp: 2030-11-02→ Common Stock (165,000 underlying)
Footnotes (1)
- [F1]The options shall vest as to one-third (1/3) of the total shares on November 2, 2021, after which the remaining two-thirds (2/3) of the total shares shall vest in eight successive equal quarterly installments.
Documents
Issuer
ADiTx Therapeutics, Inc.
CIK 0001726711
Entity typeother
Related Parties
1- filerCIK 0001527535
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 9:31 PM ET
- Size
- 7.6 KB